Interpretation of the World Health Organization guideline on glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults. // Precision Medication. – URL: https://www.sciencedirect.com/science/article/pii/S2950523226000424?dgcid=rss_sd_all
Interpretation of the World Health Organization guideline on glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults. Precision Medication. https://www.sciencedirect.com/science/article/pii/S2950523226000424?dgcid=rss_sd_all
“Interpretation of the World Health Organization guideline on glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults.” Precision Medication.
@article{article31773,
title = {Interpretation of the World Health Organization guideline on glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults},
journal = {Precision Medication},
url = {https://www.sciencedirect.com/science/article/pii/S2950523226000424?dgcid=rss_sd_all}
}
Publication date: Available online 18 September 2026 Source: Advanced Exercise and Health Science Author(s): Genevieve F.J. Nihill, David R. Lubans, Myles D. Young, Sally A. Hunt, Angus A. Leahy